One of the things I love most about radiotherapy is the constant technological advancement. This is an important piece of work at a time where RTTs are seeing significant changes. www.tipsro.science/article/S240...

Day 3 of the AACR Special Conference on Innovations in Kidney Cancer Research will feature plenary sessions on modeling disease as well as oncogenes and tumor suppressors. #AACRkidney26

#ESTRO consensus guidelines on #GTV delineation and dose-escalation in #rectalcancer, published in ctRO, Clinical and Translational Radiation Oncology. 👉 bit.ly/4cnC4me #openaccess #radiotherapy #radiationoncology #guideline

ALK+ #lungcancer often means staying on a TKI for years. If radiotherapy is needed for brain metastases or a growing spot, the big question is whether to continue the drug. New ESMO–ESTRO guidance says combining them can increase side effects. #LCSM www.sciencedirect.com/science/arti...

NOTABLE ARTICLE, January 2026 #MedicalPhysics: A generalizable dose prediction model for automatic radiotherapy planning based on physics‐informed priors and large‐kernel convolutions https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.70272#MedicalPhysics Please join us in congratulating Tianyu Xiong et al

At #BTOG26, consultants will host a Career Development Session for Trainees - An informal session for trainees of any grade interested in a career in thoracic oncology: Ask questions and chat to consultants from different specialties, all experienced in mentoring and career advice. Sanjay Popat#BTOG26

On World Cancer Day, we honor everyone who’s been touched by cancer. We’re announcing a new traveling museum exhibition, The Journey to End Cancer: From Cause to Cure, presented by MD Anderson. Join us on the journey to end cancer. spr.ly/63327hynKT #OncSky #EndCancer

Why does funding for clinical research matter? Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients. 👉 Like and reshare this message to highlight why cancer research matters. #WorldCancerDay #EORTCimpact #CancerResearch

We’re pleased that abiraterone can now be offered to thousands more men affected by prostate cancer. Read more about this decision and what it means: cruk.ink/3LzxTbS

An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy, just published in PhiRO - Physics and Imaging in Radiation Oncology. 👉 bit.ly/3Ydzyql

📣 ESTRO 2026 Pre-Meeting Webinars Get ready for #ESTRO26 with two online pre-meeting webinars ahead of the congress in Stockholm (15–19 May 2026). Cases will be discussed — we can’t wait to engage with you! 🔗 Info & registration: bit.ly/4pAM9PH #PMCwebinars #ESTRO26

As part of the World Cancer Day 2026 campaign, IPOS is hosting an insightful webinar to spotlight the key findings from the recently published Lancet Oncology Commission report, “The Human Crisis in Cancer.” Free for everyone ipos-society.org/event-6480465

📢 Join the ESTRO course in Rome to boost your skills in SRS/SRT for brain metastases & skull base lesions! 📅 26–28 March 2026 ⏰ Early deadline: 7 Jan 2026 👨‍🏫 Course Director: Maximilian Niyazi 🔗 Register: bit.ly/44BetJJ #ESTROSchool26 #SRS #SRT #Radiotherapy

Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian Cohort @cancer-control.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #carcinoma #biomarkers #oncology #prognosis

📢 The NPCA State of the Nation Report 2025 is OUT! Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca... @natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social Please share!

🗣️ New #ESTROWebinar! Management of SCLC in the Immunotherapy Era 🗓 5 Nov | 17:00–18:00 CET Chaired by Prof Corinne Faivre-Finn & Dr Suraiya Dubash (UK) 💻 Live Q&A with experts! More info & Registration here: 👉 bit.ly/3KAbjPB #RadiationOncology #LungCancer #SCLC #Immunotherapy #Webinar

📢 The first-ever ESTRO Clinical Workshop is coming to Vienna | 12–13 Mar 2026! Spots are limited—don’t miss out. 📌 Submit your motivational statement by 22 Oct to secure your place. 💻 Apply now 👉 bit.ly/47wlj5G #ESTROCLIN26 #ClinicalWorkshop #RadiationOncology

💡 Discover the latest in mutation-driven lung cancer research. Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together. 📅 13 Nov | 📍 The View, London 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer

Calling all Young and Early Career Cancer Nurses (YECCN) The YECCN MIG is currently looking for 1x MIG Chair, 1x secretary and 8x committee members. If interested & under 35/working for <5yrs, please email by 5th October, a 300 word expression of interest to: [email protected] #YECCN

Exciting news! We’ve launched ASCO Edge, an online oncology practice management educational series exclusively available to ASCO members. Get started today: brnw.ch/21wVVu3

Please check out this from We Own It. weownit.org.uk/act-now/new-...

Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC @drewmoghanaki.bsky.social @gerryhanna.bsky.social oncodaily.com/voices/drew-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCLC #LungCancer

Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the #radiotherapy delineation benchmark case procedure, published in the Green Journal. 👉 Read it before your patients: bit.ly/4fLoatJ

New #radiotherapy innovations are being stifled by the tortuous commissioning process. Patients deserve better! #radonc #oncology #medtwitter Postcode lottery for new cancer treatments, doctors warn - BBC News www.bbc.co.uk/news/article...

📢 Attending #EAPM2025 this week? Today, our @eortc.org #QualityofLife Group member Ines Rathgeber will report on the development of an e-learning course focusing on the use of EORTC PRO measures for quality of life assessment in clinical practice 👇 eapm.eu.com/2025-eapm-co... #CancerResearch

✅ Finished treatment or on maintenance for #PancreaticCancer? We’ve got resources to help. Find tips on managing side effects, eating well, coping with scanxiety, and staying up to date on the latest research. https://bit.ly/4lX0owd #GuideToAction #LetsWinPC

One Voice for Radiotherapy: Creating World Radiotherapy Awareness Day oncodaily.com/insight/one-... #Cancer #Oncology #OncoDaily #Health #Medicine

Putting Patients First: Transforming Cancer Diagnosis, Treatment and Care Through Patient-Centred Approaches. In this guest editorial, we reflect on why meaningful progress & the delivery of high quality cancer care requires more than technical innovation www.radiographyonline.com/article/S107...

Today on #WorldLungCancerDay, we reaffirm our mission to support thoracic oncology professionals and advocate for equitable, world-class care for all patients. Together, we strive to match the best survival rates globally. 💙 #WLCD2025 #LungCancerAwareness #LCSM #lungcancer

🧠 Why does glioblastoma always outsmart treatment? In our #Neuro-Oncology paper, we identified proneural-mesenchymal hybrid glioblastoma cells that are resistant to therapy and dependent on nuclear import. doi.org/10.1093/neuo... Short walkthrough below. Let’s dive in! 🧵 (1/9) #GBM, #BrainTumor

BREAKING NEWS Scientists at the @icr-ctsu.bsky.social have discovered how to predict which ER+ HER2+ cancers have a higher risk of recurrence in just 2 weeks! Breaking news - Breast Cancer Breakthrough! #breastcancer youtube.com/shorts/3rYUU...

important listen for all involved in #radiotherapy. pca.st/episode/a767...

✨Today is #BrachytherapyAwarenessDay, let's spotlight precision in cancer care. 🎯#Brachytherapy boosts survival, helps preserve function & QoL, yet remains underused. 📢 Oncology professionals: ✅ Raise awareness ✅ Support access ✅ Empower patients 👉https://bit.ly/4lwRdTL

At #ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.” 💬 With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end. 👉 bit.ly/3Iavy59

Congratulations to our journal TipsRO - Technical Innovations and Patient Support in Radiation Oncology for achieving its first Impact Factor of 2.8! A reflection of the quality and dedication of the editorial team, authors, and the entire #RTT community.

A really educational day. Big shoutout to Tom Rackley & Rebecca Muirhead for leading the event & superstars @alison-tree.bsky.social and Dione Lother for sharing their wisdom. Amazing practical insights from @aileenduffton.bsky.social @marina-khan.bsky.social Helen Grimes & Joe Flaherty. Congrats!

We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social

Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology @alison-tree.bsky.social @harshanigreen.bsky.social Full-text link: authors.elsevier.com/a/1lFrI3lXQo...

"We’re very clear that research inclusion is essential—not political. If your research isn’t representative, it’s not going to improve outcomes across our population." Lucy Chappell, chief executive @nihr.bsky.social, explains why research inclusion is vital www.bmj.com/content/389/...

Are you an experienced #Biostatistician looking for the next step in your #ClinicalTrials career? We are recruiting for a research group leader to develop and grow our academic clinical trials portfolio. Find out more and apply here: #StatsJobs #ResearchJobs 🧪 jobs.icr.ac.uk/vacancies/12...

🧠📸 Proud to represent RTTs as part of the 2022 ESTRO Physics Workshop IGRT Working Group! Our expert consensus on optimising CBCT doses for IGRT is now available. 🔗 doi.org/10.1016/j.ra... #MedPhysics #Radiotherapy #IGRT #ESTRO2022 #MedicalImaging #RadiationOncology #RTT

Come and join us in Newcastle in November for all things #SABR at this years @uksabr.bsky.social #RTT #MedPhys #ClinOnc #Radiotherapy

📰 BREAKING: Researchers show that pembrolizumab, an immunotherapy drug, helps head and neck cancer patients live years longer cancer-free. The drug also hunts down cancer trying to spread. Results from the the phase III KEYNOTE-689 trial are presented at #ASCO25 ⤵️ www.icr.ac.uk/about-us/icr...

2x free passes for UKONS 2025 via Paxman Scalp Cooling Here’s how… 1. Submit a poster abstract by 13th June (ideally) with a focus on scalp cooling (alongside guidelines on UKONS website) to [email protected] 2. Two applicants are guaranteed delegate passes to the event. #UKONS

What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!

Last chance at #ESTRO25! From streamlining workflows to enabling maskless head & neck treatments, AlignRT delivers unmatched precision and efficiency in radiation therapy. Stop by booth 240 to see AlignRT in action.

Congratulations to EMBRACE Collaborative Group for Donal Hollywood Award! EMBRACE trials set the clinical standard for cervical cancer RT. #ESTRO25 #ESTRO2025

Congratulations Corinne on the @ESTRO_RT #BreurAward Do we have parity of women in leadership? NO #ESTRO25 @mcrcnews.bsky.social @uniofmanchester.bsky.social @mguckenberger.bsky.social

Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25